The hypersomnia treatment market is projected to grow from USD 3.6 billion in 2025 to USD 5.2 billion by 2035, at a CAGR of 3.7%. Narcolepsey-1 will dominate with a 40.0% market share, while stimulants will lead the treatment type segment with a 45.0% share.